Search results
Results from the WOW.Com Content Network
As more promising vaccine news poured in, Wall Street rallied on Monday morning. The boost in the market came after AstraZeneca announced that its COVID-19 vaccine had an efficacy rate of 70.4% ...
Investors weighed new COVID-19 infections against the rapidly unfolding timetable for vaccine deployment. Stock market news live updates: Wall Street rallies on Oxford/AstraZeneca vaccine; Yellen ...
Early signs of the shift came Wednesday, when positive data for one of Pfizer Inc’s <PFE.N> COVID-19 vaccine candidates sent shares of the large U.S. drugmaker up more than 3%. Although the news ...
While fears of COVID-19 dominated investors' attention for much of 2020 and 2021, Pfizer confirms it could make variant vaccine in 100 days with the ability to make four billion doses in the first ...
A study on the effectiveness of a first dose of the Pfizer–BioNTech or Oxford–AstraZeneca COVID-19 vaccines against COVID-19 related hospitalisation in Scotland was based on a national prospective cohort study of 5.4 million people. Between 8 December 2020 and 15 February 2021, 1,137,775 participants were vaccinated in the study, 490,000 of ...
A May 2020 poll concluded that 54% of people in the U.S. felt the federal government was doing a poor job in stopping the spread of COVID-19 in the country. 57% felt the federal government was not doing enough to address the limited availability of COVID-19 testing. 58% felt the federal government was not doing enough to prevent a second wave ...
Boxes of AstraZeneca's COVID-19 vaccine from India are delivered in Brazil (January 2021). Coordination of international air cargo is an essential component of time- and temperature-sensitive distribution of COVID‑19 vaccines, but, as of September 2020, the air freight network is not prepared for multinational deployment.
Wall Street is moving some bets on COVID-19 vaccines to large pharmaceutical companies with robust manufacturing capabilities, signaling that a love affair with small biotech firms might be ending ...